Pulmonary 5-HT 2B receptor expression in fibrotic interstitial lung diseases.

Anna Löfdahl, Annika Nybom, Jenny Wigén, Göran Dellgren, Hans Brunnström, Christina Wenglén, Gunilla Westergren-Thorsson

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

Pulmonary fibrosis is a severe condition in interstitial lung diseases (ILD) such as idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-ILD, where the underlying mechanism is not well defined and with no curative treatments available. Serotonin (5-HT) signaling via the 5-HT 2B receptor has been recognized as a promising preclinical target for fibrosis. Despite this, the involvement of the 5-HT 2B receptor in fibrotic ILD is widely unexplored. This work highlights the spatial pulmonary distribution of the 5-HT 2B receptor in patients with IPF and systemic sclerosis-ILD. We show that the 5-HT 2B receptor is located in typical pathological structures e.g. honeycomb cysts and weakly in fibroblast foci. Together with immunohistochemistry and immunofluorescence stainings of patient derived distal lung tissues, we identified cell targets for 5-HT 2B receptor interference in type II alveolar epithelial cells, endothelial cells and M2 macrophages. Our results emphasize the role of 5-HT 2B receptor as a target in lung fibrosis, warranting further consideration in targeting fibrotic ILDs.

Originalspråkengelska
Artikelnummer152024
Sidor (från-till)1-8
TidskriftActa Histochemica
Volym125
Nummer3
DOI
StatusPublished - 2023

Bibliografisk information

Copyright © 2023. Published by Elsevier GmbH.

Ämnesklassifikation (UKÄ)

  • Lungmedicin och allergi

Fingeravtryck

Utforska forskningsämnen för ”Pulmonary 5-HT 2B receptor expression in fibrotic interstitial lung diseases.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här